Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.10−0.20 (-0.86%)
Close on Nov 17, 2026Market cap $462.26MP/E –Yield –
Neurogene operating margin
Operating margin is operating income as a percentage of revenue.
Neurogene's operating margin for the twelve months ending Dec 31, 2024 was -8930.3%. For fiscal 2024 it was -8930.3%, against -130.5% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -8930.3% | −8799.8 |
| FY2018 | Dec 31, 2018 | -130.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -2176.6% | – |
| Q2 FY2018 | Jun 30, 2018 | 10.8% | – |
See a number that looks wrong?